{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:06:05Z","timestamp":1715040365653},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.2165\/11641360-000000000-00000","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T21:20:07Z","timestamp":1362518407000},"page":"199-206","source":"Crossref","is-referenced-by-count":0,"title":["Identifying and Managing Patients at High Risk for Fractures"],"prefix":"10.1007","volume":"12","author":[{"given":"Esteban J\u00f3dar","family":"Gimeno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,23]]},"reference":[{"issue":"240","key":"12040199_CR1","first-page":"569","volume":"6","author":"B Aubry-Rozier","year":"2010","unstructured":"Aubry-Rozier B, Lamy O. Fracture risk, new treatments: how does the management of the osteoporosis of elderly change? Rev Med Suisse 2010 Mar 17; 6(240): 569\u201370, 572\u20134","journal-title":"Rev Med Suisse"},{"issue":"1","key":"12040199_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S1516-31802010000100006","volume":"128","author":"ML Steiner","year":"2010","unstructured":"Steiner ML, Fernandes CE, Strufaldi R, et al. Application of Osteorisk to postmenopausal patients with osteoporosis. Sao Paulo Med J 2010 Jan; 128(1): 24\u20139","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"12040199_CR3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jbmr.12","volume":"25","author":"FA Tremollieres","year":"2010","unstructured":"Tremollieres FA, Pouilles JM, Drewniak N, et al. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res 2010 May; 25(5): 1002\u20139","journal-title":"J Bone Miner Res"},{"key":"12040199_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2474-12-30","volume":"12","author":"R Azagra","year":"2011","unstructured":"Azagra R, Roca G, Encabo G, et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX tool in Spain. BMC Musculoskelet Disord 2011 Jan 28; 12: 30","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"12040199_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00198-009-0975-1","volume":"21","author":"K Lippuner","year":"2010","unstructured":"Lippuner K, Johansson H, Kanis JA, et al. FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int 2010 Mar; 21(3): 381\u20139","journal-title":"Osteoporos Int"},{"issue":"6","key":"12040199_CR6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00198-009-1056-1","volume":"21","author":"AZ LaCroix","year":"2010","unstructured":"LaCroix AZ, Beck TJ, Cauley JA, et al. Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density? Osteoporos Int 2010 Jun; 21(6): 919\u201329","journal-title":"Osteoporos Int"},{"issue":"11","key":"12040199_CR7","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1210\/jc.2007-2836","volume":"93","author":"CL Cheung","year":"2008","unstructured":"Cheung CL, Sham PC, Chan V, et al. Identification of LTBP2 on chromosome 14q as a novel candidate gene for bone mineral density variation and fracture risk association. J Clin Endocrinol Metab 2008 Nov; 93(11): 4448\u201355","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"12040199_CR8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00198-010-1386-z","volume":"22","author":"S Blaizot","year":"2011","unstructured":"Blaizot S, Delmas PD, Marchand F, et al. Risk factors for peripheral fractures vary by age in older men\u2014the prospective MINOS study. Osteoporos Int 2011 Jun; 22(6): 1755\u201364","journal-title":"Osteoporos Int"},{"issue":"3","key":"12040199_CR9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00198-010-1477-x","volume":"22","author":"A Lih","year":"2011","unstructured":"Lih A, Nandapalan H, Kim M, et al. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int 2011 Mar; 22(3): 849\u201358","journal-title":"Osteoporos Int"},{"issue":"12","key":"12040199_CR10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001 Dec; 12(12): 989\u201395","journal-title":"Osteoporos Int"},{"issue":"7","key":"12040199_CR11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1359\/jbmr.2002.17.7.1237","volume":"17","author":"JA Kanis","year":"2002","unstructured":"Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002 Jul; 17(7): 1237\u201344","journal-title":"J Bone Miner Res"},{"issue":"3","key":"12040199_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-004-1689-z","volume":"16","author":"C Laet De","year":"2005","unstructured":"De Laet C, Oden A, Johansson H, et al. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 2005 Mar; 16(3): 313\u20138","journal-title":"Osteoporos Int"},{"issue":"Suppl. 1","key":"12040199_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2565(08)71780-6","volume":"208","author":"J Gonz\u00e1lez Mac\u00edas","year":"2008","unstructured":"Gonz\u00e1lez Mac\u00edas J, Gua\u00f1abens Gay N, G\u00f3mez Alonso C, et al. Gu\u00edas de pr\u00e1ctica cl\u00ednica en la osteoporosis posmenop\u00e1usica, glucocorticoidea y del var\u00f3n. Sociedad Espa\u00f1ola De Investigaci\u00f3n \u00d3sea Y Del Metabolismo Mineral. Rev Clin Esp 2008 May; 208 (Suppl. 1): 1\u201324","journal-title":"Rev Clin Esp"},{"issue":"6","key":"12040199_CR14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4158\/EP.16.6.1016","volume":"16","author":"NB Watts","year":"2010","unstructured":"Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract 2010 Nov\u2013Dec; 16(6): 1016\u20139","journal-title":"Endocr Pract"},{"issue":"17","key":"12040199_CR15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010 Nov 23; 182(17): 1864\u201373","journal-title":"CMAJ"},{"issue":"2","key":"12040199_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 2009 Feb 20; 62(2): 105\u20138","journal-title":"Maturitas"},{"issue":"4","key":"12040199_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008 Apr; 19(4): 399\u2013428","journal-title":"Osteoporos Int"},{"issue":"1","key":"12040199_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1043-2760(99)00214-3","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Torgerson D, Cooper C. Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000 Jan\u2013Feb; 11(1): 28\u201332","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"12040199_CR19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1503\/cmaj.111-2031","volume":"183","author":"E Vos","year":"2011","unstructured":"Vos E. Osteoporosis guidelines miss big picture. CMAJ 2011 Apr 5; 183(6): 695","journal-title":"CMAJ"},{"issue":"4","key":"12040199_CR20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2265.2010.03844.x","volume":"73","author":"NJ Crabtree","year":"2010","unstructured":"Crabtree NJ, Bebbington NA, Chapman DM, et al. Impact of UK national guidelines based on FRAX\u00ae\u2014comparison with current clinical practice. Clin Endocrinol (Oxf) 2010 Oct; 73(4): 452\u20136","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"12040199_CR21","first-page":"79","volume":"2","author":"E J\u00f3dar Gimeno","year":"2010","unstructured":"J\u00f3dar Gimeno E. Conclusiones consensuadas del I Foro Multidisciplinar en el Manejo del Paciente con Alto Riesgo de Fractura (ARF) Osteopor\u00f3tica. Rev Osteoporos Metab Miner 2010 Jul; 2(2): 79\u201386 [online]. Available from URL: http:\/\/www.revistadeosteoporosisymetabolismomineral.com\/pdf\/articulos\/12010020200790086.pdf [Accessed 2012 Nov 15]","journal-title":"Rev Osteoporos Metab Miner"},{"issue":"1","key":"12040199_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1185\/03007990802645461","volume":"25","author":"D Hosking","year":"2009","unstructured":"Hosking D, Alonso CG, Brandi ML. Management of osteoporosis with PTH: treatment and prescription patterns in Europe. Curr Med Res Opin 2009 Jan; 25(1): 263\u201370","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"12040199_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/ciia.2007.2.1.163","volume":"2","author":"E J\u00f3dar-Gimeno","year":"2007","unstructured":"J\u00f3dar-Gimeno E. Full length parathyroid hormone (1\u201384) in the treatment of osteoporosis in postmenopausal women. Clin Interv Aging 2007; 2(1): 163\u201374","journal-title":"Clin Interv Aging"},{"issue":"7","key":"12040199_CR24","first-page":"363","volume":"193","author":"VF Gil","year":"1993","unstructured":"Gil VF, Belda J, Munoz C, et al. Validity of four indirect methods which evaluate therapeutic compliance for arterial hypertension. Rev Clin Esp 1993 Nov; 193(7): 363\u20137","journal-title":"Rev Clin Esp"},{"issue":"4","key":"12040199_CR25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1017\/S0266462300103101","volume":"16","author":"Appraisal of Guidelines, Research,Evaluation in Europe AGREE Collaborative Group","year":"2000","unstructured":"Appraisal of Guidelines, Research, and Evaluation in Europe (AGREE) Collaborative Group. Guideline development in Europe: an international comparison. Int J Technol Assess Health Care 2000 Autumn; 16(4): 1039\u201349","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"12040199_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","volume":"12","author":"AGREE Collaboration","year":"2003","unstructured":"AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003 Feb; 12(1): 18\u201323","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"12040199_CR27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S026646230300014X","volume":"19","author":"JS Burgers","year":"2003","unstructured":"Burgers JS, Cluzeau FA, Hanna SE, et al. Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada. Int J Technol Assess Health Care 2003 Winter; 19(1): 148\u201357","journal-title":"Int J Technol Assess Health Care"},{"issue":"15","key":"12040199_CR28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, et al. Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999 Oct 20; 282(15): 1458\u201365","journal-title":"JAMA"},{"key":"12040199_CR29","volume-title":"Osteoporos Int. Epub","author":"J Sanf\u00e9lix-Genov\u00e9s","year":"2012","unstructured":"Sanf\u00e9lix-Genov\u00e9s J, Sanf\u00e9lix-Gimeno G, Peir\u00f3 S, et al. Prevalence of osteoporotic fracture risk factors and anti-osteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporos Int. Epub 2012 May 23"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2165\/11641360-000000000-00000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T22:17:33Z","timestamp":1715033853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/11641360-000000000-00000"}},"subtitle":["Conclusions from the Second Spanish Multidisciplinary Forum\u2014Parathyroid Hormone Use in Osteoporotic Patients at High Risk for Fractures"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["12040199"],"URL":"https:\/\/doi.org\/10.2165\/11641360-000000000-00000","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}